Synedica Cagri Reta 40mg/4mg: Advanced Peptide Combination Formula
Synedica Cagri Reta combines two extensively researched peptide compounds, Retatrutide and Cagrilintide, in a convenient dual pen package. Each package contains two prefilled pens formulated with a total of 40mg of Retatrutide and 4mg of Cagrilintide.
These compounds have generated substantial interest within the scientific and research communities due to their involvement in metabolic regulation, appetite signaling, and energy balance pathways. Synedica reta/cagri is manufactured with a focus on product quality, consistency, and transparent ingredient specifications.
According to the product packaging, the kit contains:
- 1 pen containing 4mg Cagrilintide
- 1 pen containing 40mg Retatrutide
- 12 disposable needles
- 1 instruction book
The packaging identifies the product as a Cagrilintide & Retatrutide Dual Pen Kit and indicates a once-weekly format.
Cagrilintide and retatrutide are investigated independently in scientific research involving metabolic and appetite-related pathways. This combined product is supplied as two separate pens rather than a single combined formulation.
Product Contents
Each Synedica Cagri Reta package includes:
- Two prefilled pens
- Retatrutide 40mg pen
- Cagrilintide 4mg pen
- 12 disposable needles included
- Instruction book included
- Clearly identified ingredient strengths
- Secure, tamper resistant packaging
- Detailed product labeling and storage information
Reta and Cagri: The Active Compounds
Retatrutide
Retatrutide is a next generation peptide currently being investigated for its effects on multiple metabolic pathways. Scientific studies continue to evaluate its interaction with hormone receptors involved in energy expenditure, glucose regulation, and body weight management.
Cagrilintide
Cagrilintide is a long acting amylin analogue that has been studied for its influence on appetite regulation and satiety signaling. Ongoing research continues to explore its biological characteristics and potential applications in metabolic science.
Key Product Features
- Combination formula containing Retatrutide and Cagrilintide
- Dual pen packaging for convenience and product identification
- Transparent ingredient concentrations
- Quality focused manufacturing standards
- Comprehensive product labeling
- Secure packaging designed for proper storage and handling
- Research relevant compounds under active scientific investigation
- Consistent formulation and quality control procedures
Why Choose Synedica Cagri and Reta?
- Transparent Formulation
Synedica Reta/Cagri provides clearly defined ingredient concentrations and product specifications, ensuring complete transparency regarding formulation details.
- Quality Assured Manufacturing
Each product is produced according to stringent quality control procedures that emphasize consistency, accuracy, and reliable product identification.
- Scientifically Recognized Compounds
Retatrutide and Cagrilintide remain subjects of extensive scientific research due to their unique biological mechanisms and growing relevance within metabolic studies.
- Practical Packaging
The dual pen format offers convenient handling, clear identification, and support for proper storage according to manufacturer recommendations.
- Comprehensive Product Information
Detailed labeling provides easy access to ingredient information, product specifications, and storage guidance.
Reta/Cagri Specifications
| Feature | Details |
|---|---|
| Product Name | Synedica Cagri Reta |
| Retatrutide Content | 40mg |
| Cagrilintide Content | 4mg |
| Package Contents | 2 Pens |
| Product Category | Peptide Formula |
| Packaging | Securely Sealed |
Storage Recommendations
To help preserve product integrity and quality:
- Store according to manufacturer instructions.
- Protect from excessive heat, moisture, and direct sunlight.
- Maintain recommended storage conditions at all times.
- Do not use if the packaging appears damaged or compromised.
- Keep out of reach of children and pets.
⚠️Important Notice: Retatrutide and Cagrilintide may be subject to prescription requirements, regulatory restrictions, or ongoing clinical evaluation depending on local laws and regulations. Any decisions regarding suitability, administration, dosage, safety, or use should be discussed with a qualified healthcare professional.
Reviews
There are no reviews yet.